Method of non-systemically fighting against parasites and agent therefor
7 claims: 2 independent, 5 dependent
- 1Patent claims Zastrzeżenia patentowe 1. The use of compounds that are agonists and antagonists of nicotinergic acetylcholine receptors in insects, which are compounds of the general formula II for the non-systemic control of parasitic insects, especially fleas in animals and lice in humans, wherein in formula 2 an is 0, 1 or 2;1. Zastosowanie związków będących agonistami i antagonistami nikotynergicznych receptorów acetylocholiny u owadów, które stanowią związki o ogólnym wzorze 2 a do naskómego, niesystemicznego zwalczania pasożytniczych owadów, zwłaszcza pcheł u zwierząt i wszy u ludzi, przy czym we wzorze 2 a n oznacza 0, 1 lub 2;Aryl means phenyl Aryl oznacza fenyl Heteroaryl means thienyl, furyl, thiazolyl, imidazolyl, pyridyl, benzothiazolyl, Heteroaryl oznacza tienyl, furyl, tiazolil, imidazolil, pirydyl, benzotiazolil, Subst. is hydrogen or halogen;Subst. oznacza atom wodoru lub chlorowca;E is NO 2 or CN;E oznacza NO 2 lub CN;X is -CH = or -N =;X oznacza ugrupowanie -CH= lub -N=;A is a hydrogen atom as well as a C 1 -C 4 -alkyl group. Z is an optionally substituted C 1 -C 4 -alkyl group or -NRR, wherein R may be the same or different and R is a hydrogen atom or a C 1 -C 4 -alkyl group. A oznacza atom wodoru jak również grupę C1-C4-alkilowąZ oznacza ewentualnie podstawioną grupę Ci-C 4-alkilową lub -NRR, przy czym R mogą być takie same lub różne i R oznacza atom wodoru lub grupę Ci-C 4-alkilową, A and Z together with the atoms to which they are attached can form a saturated or unsaturated heterocyclic ring containing 5 or 6 ring members, and which can contain a further 1 or 2 the same or different heteroatoms and / or heterogroups selected from oxygen, sulfur or nitrogen or an N-C 1 -C 4 -alkyl group. A i Z wraz z atomami z którymi są one połączone mogą utworzyć nasycony lub nienasycony pierścień heterocykliczny zawierający 5 lub 6 członów w pierścieniu, i który może zawierać dalsze 1 lub 2 takie same albo różne heteroatomy i/lub heterogrupy wybrane z tlenu, siarki lub azotu lub grupy N-Ci-C 4-alkilowej.
- 7Molded material for non-systematic control of parasitic insects, including lice, fleas in animals, especially collars or tags, for collars, of thermoplastic plastic or possibly of thermoplastic elastomer as a carrier containing the active substance, characterized in that as the active substance contains a compound with formula 2 a as defined in claim 1. 7. Kształtka do naskómego, niesystemicznego zwalczania pasożytniczych owadów, w tym wszy, pcheł u zwierząt, zwłaszcza obroża lub przywieszka, do obroży, z termoplastycznego tworzywa sztucznego lub ewentualnie z termoplastycznego elastomeru jako nośnika zawierającego substancję czynną, znamienna tym, ze jako substancję czynną zawiera związek o wzorze 2 a określony w zastrz. 1. 190 280 190 280 Niniejszy wynalazek dotyczy nowego zastosowania związków będących agonistami i antagonistami nikotynergicznych receptorów acetylocholiny u owadów do naskómego, niesystemicznego zwalczania pasożytniczych owadów u ludzi i u zwierząt oraz kształtki do naskómego, niesystemicznego zwalczania pasożytniczych owadów. The present invention relates to a new use of compounds that are agonists and antagonists of nicotinergic acetylcholine receptors in insects for epidermis, non-systematic control of parasitic insects in humans and animals, and moldings for epidermal, non-systematic control of parasitic insects. Compounds that are agonists or antagonists of nicotinergic acetylcholine receptors in insects are known. These include nicotinyl insecticides, in particular chloronicotinyl insecticides. It is also known that these compounds are particularly effective in controlling insects that are plant pests. Znane są związki, będące agonistami lub antagonistami nikotynergicznych receptorów acetylocholiny u owadów. Zalicza się do nich nikotynylowe środki owadobójcze, a zwłaszcza chloronikotynylowe środki owadobójcze. Wiadomo tez, ze związki te są szczególnie skuteczne w zwalczaniu owadów, będących szkodnikami roślin. The systemic effects of these compounds in plants on insects that are plant pests are also known. Znane jest również systemiczne oddziaływanie tych związków w roślinach na owady, będące szkodnikami roślin. PCT Application No. WO 93/24 002 discloses that certain 1- [N- (halo-3-pyridylmethyl)] - N-methylamino-1-alkylamino-2-nitroethylene derivatives are suitable for systemic use in controlling fleas in animals households. According to this method of use, the active substance is administered orally or parenterally to a pet animal, for example in the form of an injection;in this way it enters the pet's blood circulation system. The active substance then goes to the fleas as they suck blood. In application No. WO 93/24 002, an unsymmetrical type of use was considered unsuitable for controlling fleas in domestic animals. W zgłoszeniu PCT nr WO 93/24 002 ujawniono, ze określone pochodne 1-[N-(halogeno-3-pirydylometylo)]-N-metyloamino-1-alkiloamino-2-nitroetylenu nadają się do systemicznego zastosowania w celu zwalczania pcheł u zwierząt domowych. Zgodnie z takim sposobem zastosowania, substancję czynną podaje się zwierzęciu domowemu doustnie lub pozajelitowe, na przykład w postaci zastrzyku;przedostaje się ona w ten sposób do układu krążenia krwi zwierzęcia domowego. Substancja czynna trafia następnie do pcheł w trakcie ssania przez nie krwi. W zgłoszeniu nr WO 93/24 002 niesymetryczny rodzaj zastosowania uznano za nieodpowiedni do zwalczania pcheł u zwierząt domowych. It has now surprisingly been found that compounds that are simply agonists or antagonists of nicotinergic acetylcholine receptors in insects are useful for non-systematic control of parasitic insects such as fleas, lice or flies in humans and animals. Obecnie nieoczekiwanie wynaleziono, że związki będące wprost agonistami lub antagonistami nikotynergicznych receptorów acetylocholiny u owadów są przydatne do niesystemicznego zwalczania pasożytniczych owadów, takich jak pchły, wszy lub muchy u ludzi i u zwierząt. Compounds that are agonists or antagonists of nicotinergic acetylcholine receptors in insects are known, for example, from European Patent Publication Nos. 464 830, 428 941, 425 978, 386 565, 383 091, 375 907, 364 844, 315 826, 259 738, 254 859, 235 725, 212 600, 192 060, 163 855, 154 178, 136 636, 303 570, 302 833, 306 696, 189 972, 455 000, 135 956, 471 372, 302 389;German Lining Descriptions No. 3 639 877, 3 712 307;Japanese Lining Descriptions No. 03 220 176, 02 207 083, 63 307 857, 63 287 764, 03 246 283, 04 9371, 03 279 359, 03 255 072;U.S. Patent Nos. 5,034,524, 4,944,898, 4,918,866, 5,039 686, 5,034 404;PCT applications nos. WO 91/17 659, 91/4965;French Application No. 2 611 114;Brazilian Application No. 88 03 621. The methods, methods, formulas and definitions described in these publications, as well as detailed procedures and individual compounds are expressly referred to in this application. Związki, będące agonistami lub antagonistami nikotynergicznych receptorów acetylocholiny u owadów są znane na przykład z europejskich opisów wyłożeniowych nr 464 830, 428 941, 425 978, 386 565, 383 091, 375 907, 364 844, 315 826, 259 738, 254 859, 235 725, 212 600, 192 060, 163 855, 154 178, 136 636, 303 570, 302 833, 306 696, 189 972, 455 000, 135 956, 471 372, 302 389;niemieckich opisów wyłożeniowych nr 3 639 877, 3 712 307;japońskich opisów wyłożeniowych nr 03 220 176, 02 207 083, 63 307 857, 63 287 764, 03 246 283, 04 9371, 03 279 359, 03 255 072;opisów patentowych Stanów Zjednoczonych Ameryki nr 5 034 524, 4 948 798, 4 918 086, 5 039 686, 5 034 404;zgłoszeń PCT nr WO 91/17 659, 91/4965;francuskiego zgłoszenia nr 2 611 114;brazylijskiego zgłoszenia nr 88 03 621. Opisane w tych publikacjach metody, sposoby, wzory i definicje, jak również szczegółowe sposoby postępowania i poszczególne związki są w niniejszym zgłoszeniu wyraźnie przywołane.
Independent claims2
491 paragraphs in 24 sections, as filed
The subject of the invention is the use of compounds that are agonists and antagonists of nicotinergic acetylcholine receptors in insects, which are compounds of the general formula 2a for non-systemic control of parasitic insects, especially fleas in animals and lice in humans, wherein in formula 2 an is 0, 1 or 2;
Aryl means phenyl
Heteroaryl means thienyl, furyl, thiazolyl, imidazolyl, pyridyl, benzothiazolyl,
Subst. is hydrogen or halogen;
E is NO 2 or CN;
X is -CH = or -N =;
A is a hydrogen atom as well as a C1-C4-alkyl group. Z is an optionally substituted N-C1-C4-alkyl group or -NRR, wherein R may be the same or different and R is a hydrogen atom or a C1-C4-alkyl group .
A and Z together with the atoms to which they are attached can form a saturated or unsaturated heterocyclic ring containing 5 or 6 ring members, and which can contain a further 1 or 2 the same or different heteroatoms and / or heterogroups selected from oxygen, sulfur or nitrogen or an N-C 1 -C 4 -alkyl group.
Preferably, the skin is treated non-systemically with a compound of general formula 2a 'in which n is 1 or 2;
Heteroaryl means thisilyl or pyridyl
Subst. is chlorine, a
A, Z, X and E have the meanings given above.
190 280
Particularly preferably, the skin is treated non-systemically with a compound of general formula II in which n is 1;
Subst. is halogen; and
A, Z, X and E have the meanings given above. Particularly preferably, in the use according to the invention, the skin is treated non-systemically with a compound of general formula 2 a in which n is 1 or 2;
A, Z, X and E have the meanings given above.
In the application according to the invention, the skin is particularly preferably treated non-systemically with a compound of formula 8-12, 14-16, 18-25, 27, 29.
Particularly preferably, in the use according to the invention, the skin is treated non-systemically with a compound which is imidacloprid which is a 1 - [(6-chloro-3-pyridinio) methyl J-N-nitro-2-imidium /olidinium compound.
Another object of the invention is a molding for skin, non-systematic control of parasitic insects, including lice, fleas in animals, especially a collar or tag, for collars made of thermoplastic plastic or possibly of thermoplastic elastomer as a carrier, characterized in that it contains an active substance which is a compound of formula II as defined above.
As extremely preferred, it contains a compound of general formula 2a, wherein n is 1 or 2,
Subst. is especially halogen, in particular chlorine, and
A, Z, X and E have the above meanings.
In particular, a compound of formula 8-12, 14-16, 18-25, 27, 29 is mentioned.
The active substances of formula 2a in conditions favorable to the toxicity of warm-blooded animals are suitable for skin, non-systematic control of parasitic insects occurring in humans and in animal husbandry and breeding, in domestic and utility animals as well as kept in zoos and laboratories for experiments and being the subject of hobby. These compounds are active during all or individual stages of pest development as well as in relation to their resistant and typically sensitive types.
Equivalent for this use of compounds of formula 2a for non-systemic, non-systematic control of parasites is the method of non-systemic, non-systematic control of parasitic insects, especially fleas, lice and flies in humans and animals, characterized by the non-systematic interaction of nicotinergic acetylcholine receptor agonists and antagonists which are compounds of general formula 2 a.
Pests include:
from the order Anoplura, for example Haematopinus spp., Linognathus spp., Solenopotes spp., Pediculus spp., Pthirus spp .;
from the order Mallophaga e.g. Trimenopon spp., Menopon spp., Bomenacanthus spp., Menacanthus spp., Trichodectes spp ,, Pelicola spp., Damalinea spp., Bovicola spp .;
from the Diptera order e.g. Chrysops spp., Tabanus spp., Musca spp., Hydrotaea spp., Muscina spp., Haematobosca spp., Haematobia spp., Stomoxys spp., Fannia spp., Glossina spp., Lucilia spp., Galliphora spp. ., Auchmeramyia spp., Cordylobia spp., Cochliomyia spp., Chrysomyia spp., Sarcophaga spp., Wohlfartia spp., Gasterophilus spp., Oesteromyia spp., Oedemagena spp., Hypoderma spp., Oestrus spp. Melophagus spp., Hippobosca spp .;
from the order of the Siphonaptera e.g. Ctenocephalides spp., Echidnophaga spp., Ceratophyllus spp.
Particularly outstanding is the action against Siphonaptera, especially fleas.
Preferably, the following animals are treated with compounds: utility and farm animals, which include mammals such as, for example, oxen, horses, sheep, pigs, goats, camels, water buffaloes, donkeys, rabbits, fallow deer, reindeer, fur animals such as minks, chinchillas and raccoons, birds such as chickens, geese, turkeys, ducks;
laboratory and experimental animals, which include mice, rats, guinea pigs, yellow hamsters, dogs and cats;
hobby animals, which include dogs and cats.
190 280
The application can be both preventive and curative.
The active substance is applied directly or in the form of a suitable preparation for the skin, by treatment of the surroundings or by means of moldings containing the active substance, such as, for example, stripes, plates, bands, collars, ear tags, limb bands, marking devices.
Applying to the skin is done by bathing, dipping, pouring, pouring, washing, using shampoo, enrobing, powdering.
Suitable formulations are: diluted solutions or concentrates, dermal solutions, pour-ons, gels; skin emulsions and suspensions as well as semi-solid preparations; preparations in which the active substance is incorporated into the ointment, oil-in-water emulsion or water-in-oil emulsion on which the preparation is based; solid preparations, such as powders, shaped bodies containing the active substance.
Solutions for administration to the skin are applied by dripping, lubrication, rubbing, spraying, spraying or dipping bathing or washing.
Solutions are prepared in such a way that the active substance is dissolved in a suitable solvent and, optionally, added additional ingredients such as dissolution agents, acids, bases, buffer salts, antioxidants, preservatives.
Solvents include physiologically tolerable solvents such as water, alcohols such as ethanol, butanol, benzyl alcohol and glycerin, hydrocarbons, propylene glycol, polyoxyethylene glycols, N-methylpyrrolidone and mixtures thereof. The active substances can also optionally be dissolved in physiologically tolerated vegetable or synthetic oils.
Solvent-promoting agents are those which promote the dissolution of the active substance in the basic solvent or also prevent its precipitation. Examples are: polyvinylpyrrolidone, polyoxyethylene castor oil, polyoxyethylene sorbitan esters.
Preservatives are; benzyl alcohol, trichlorobutanol, p-hydroxybenzoic acid esters, n-butanol.
The addition of a thickener may be advantageous when preparing solutions. Thickeners are inorganic thickeners such as bentonite, colloidal silica or aluminum monostearate, and organic thickeners such as cellulose derivatives, polyvinyl alcohol) and copolymers of vinyl alcohol and polyacrylates and polymethacrylates.
Gels that are applied to or applied to the skin are made in such a way that a sufficient amount of thickener is added to the solutions obtained by the method described above to form a clear mass with an ointment consistency. The thickeners mentioned above are used as thickeners.
Pouring preparations are poured on or sprayed on a limited area of the skin, the active substance being spread over the surface of the body.
The pour-on preparations are prepared in such a way that the active substance is dissolved, dispersed or emulsified in a suitable skin-tolerant solvent or mixture of solvents. Optionally, further auxiliaries, such as dyes, antioxidants, light protective agents, and adhesion promoting agents are introduced into the system.
Solvents include: water, alkanols, glycols, polyoxyethylene glycols, polyoxypropylene glycols, glycerin, aromatic alcohols such as benzyl alcohol, phenylethanol or phenoxyethanol; esters such as ethyl acetate, butyl acetate or benzyl benzoate; ethers such as alkylene glycol alkyl ethers, e.g. dipropylene glycol monomethyl ether or diethylene glycol monobutyl ether; ketones such as acetone or methyl ethyl ketone; aromatic and / or aliphatic hydrocarbons, vegetable or synthetic oils, dimethylformamide (EMF), dimethylacetamide, N-methylpyrrolidone, 2-dimethyl-4-oxy-methylene-1,3-dioxolane.
190 280
Dyes are all animal dyes that can be formulated as a solution or suspension.
Excipients are also spreading oils, such as isopropyl myristate, dipropylene glycol pelargonate, silicone oils, fatty acid esters, triglycerides, and fatty alcohols.
Antioxidants are sulfites or metabisulfites such as potassium metabisulfite, ascorbic acid, butylated hydroxytoluene, butylated hydroxyanisole, and tocopherol.
Light protection agents are e.g. benzophenone derivatives or 1-H-benzimidazole-5-sulfonic acid.
Adhesion enhancing agents are e.g. cellulose derivatives, starch derivatives, polyacrylates, polymers of natural origin such as alginates, gelatin.
The emulsions may be in the form of water-in-oil or oil-in-water emulsions. They are prepared in such a way that the active substance dissolves in either the hydrophobic or hydrophilic phase and these phase is influenced by the addition of appropriate emulsifiers and, if necessary, by introducing other auxiliary agents, such as dyes, resorption agents, preservatives, antioxidants, anti-oxidants. the action of light, viscosity-increasing substances, homogenises with the second phase solvent.
The hydrophobic phase (oil) is: paraffin oil, silicone oil, natural vegetable oils such as sesame oil, almond oil, castor oil; synthetic triglycerides, such as biglyceride, mixtures of octane and decanoic acids, a mixture of triglycerides with vegetable fatty acids with a chain of 8-12 C atoms or other specially selected fatty acids of natural origin, a mixture of partial glycerides of saturated or unsaturated fatty acids optionally also containing hydroxyl groups , mono and diglycerides of fatty acids C<sub>8</sub>-Cio; fatty acid esters, such as ethyl stearate, di-n-butyryl adipate, lauric acid hexyl ester, dipropylene glycol pelargonate, moderate chain branched fatty acid esters with saturated fatty acids with a chain content of 16-18 C atoms, isopropyl myristate, isopropyl palmitate, esters of a mixture of octanoic and decanoic acids with saturated fatty alcohols having a chain of 12-18 C atoms, isopropyl stearate, oleic acid oleyl ester, oleic acid decyl ester, ethyl oleate, lactic acid ethyl ester, acid esters; fatty wax, such as dibutyl phthalate, diisopropyl ester of adipic acid, mixtures of esters related to the latter, including fatty alcohols such as isotridecyl alcohol, 2-octyldodecanol, cetyl stearyl alcohol, oleyl alcohol, fatty acids such as, for example, oleic acid and mixtures thereof.
The hydrophilic phase is: water, alcohols such as propylene glycol, glycerin, B-sorbitol and mixtures thereof.
Emulsifiers are: nonionic surfactants, e.g. polyoxyethylene castor oil, polyoxyethylene sorbitan monooleate, sorbitan monostearate, glycerin monostearate, polyoxyethylene glycol stearate, polyglycol alkylphenyl ethers; ampholytic surfactants such as disodium N-lauryl-p-iminodipropionate or lecithin; anionic surfactants such as sodium lauryl sulfate, fatty alcohol ether sulfates, monoethanolamine salts with orthophosphoric acid esters and polyglycol mono- and dialkyl ethers; cationic surfactants such as cetyltrimethylammonium chloride.
Other auxiliaries which may be mentioned are: viscosity-increasing and emulsion stabilizing substances such as carboxymethyl cellulose, methyl cellulose; and other cellulose and starch derivatives, polyacrylates, alginates, gelatin, acacia, polyvinylpyrrolidone, polyvinyl alcohol), copolymers of methyl vinyl ether and maleic anhydride, polyoxyethylene glycols, waxes, colloidal silica or mixtures of the above substances.
The suspensions are prepared in such a way that the active substance is dispersed in the carrier liquid, optionally adding other auxiliaries, such as wetting agents, dyes, resorption enhancers, preservatives, antioxidants, light protective agents. Potty liquids are all homogeneous solvents and solvent mixtures. As facilitators
190 Wetting (dispersants) the surfactants listed above are mentioned. Further auxiliaries listed above are mentioned as further auxiliaries.
Semi-solid preparations applied to the skin differ from the suspensions and emulsions described above only with higher viscosity.
Solid formulations are prepared in such a way that the active substance is mixed with a suitable carrier, optionally with the addition of auxiliaries, and the mixture is given the desired shape. All physiologically tolerated inert solids are mentioned as carriers. Inorganic and organic substances serve as such. Inorganic substances are, for example, table salt, carbonates such as calcium carbonate, calcium bicarbonate, various types of alumina, silicas, precipitated or colloidal silica, phosphates. Auxiliary agents are the preservatives, antioxidants and dyes discussed above. Further suitable auxiliaries are lubricants and release agents, e.g. magnesium stearate, acid; stearic, talc, bentonite.
The ready-to-use preparations contain the active substance in a concentration of 1 ppm - 20% by weight, preferably 0.01 - 10% by weight. Formulations which are diluted before use contain the active substance in a concentration of 0.5-90% by weight, preferably 1-50% by weight.
In general, in order to achieve effective results, it is recommended to use the active ingredient in an amount of from about 0.5 mg to about 50 mg, preferably 1-20 mg per day based on one kilogram of body weight.
Application in the form of fittings is particularly important. The fittings are, among others, collars, collar tags (medallions), ear tags, tapes for attaching to the limbs or trunk, adhesive strips or foils, tear-off films. Collars and collar tags are particularly important.
Thermoplastics or flexible thermoset plastics as well as elastomers and thermoplastic elastomers are taken into account for the production of the moldings. Polyvinyl resins, polyurethanes, polyacrylates, epoxy resins), cellulose, cellulose derivatives, polyamides and polyesters having sufficient miscibility with the abovementioned active substances are mentioned. The polymers must have sufficient strength and flexibility to avoid cracking or breaking during molding. They must also have sufficient durability to meet typical usage conditions. In addition, sufficient migration should take place in the polymers; active substance towards the surface of the fitting.
Polyvinyl resins include poly (vinyl halides) such as poly (vinyl chloride), vinyl chloride / vinyl acetate copolymers and poly (vinyl fluoride); polyacrylates and polymethacrylates such as poly (methyl acrylate and polymethyl methacrylate) and polyvinylbenzenes such as polystyrene and polyvinyltoluene. Poly (vinyl chloride) is especially important.
Plasticizers generally used to soften solid polyvinyl resins are suitable for producing moldings based on polyvinyl resin. The type of plasticizer used depends on the type of resin and its miscibility with the plasticizer. Suitable plasticizers include, for example, phosphoric acid esters, phthalic acid esters such as dimethyl phthalate and dioctyl phthalate, and adipic acid esters, such as diisobutyl adipate. Other esters such as azelaic acid, maleic acid, ricinoleic acid, myristic acid, palmitic acid, oleic acid, sebacic acid, stearic acid and trimellitic acid as well as complex linear polyesters, polymeric plasticizers and epoxidized soybean oil can be used. The amount of plasticizer is from about 10 to 50% by weight, preferably from about 20 to 45% by weight based on the total weight of the composition.
Moldings may also contain other ingredients such as stabilizers, lubricants, fillers and dyes that do not change the basic properties of the composition. Suitable stabilizers are antioxidants and agents that protect the fittings against ultraviolet radiation and unwanted decomposition during processing, e.g. during extrusion. Some stabilizers, such as epoxidized soybean oil, they also serve as secondary plasticizers. As lubricants, for example, stearates, stearic acid and low molecular weight polyethylene can be used. Contents of these
190 280 ingredients may be up to about 5% by weight based on the total weight of the composition.
In the process of producing moldings based on vinyl resin, the various components are mixed in a known manner and molded bodies are known by extrusion or injection molding. The choice of processing method in the production of fittings is basically technic / independent of the theological properties of the shaped material and the desired form of the fitting. The processing method can be adapted to the processing technology or to the type of fitting. Processing methods differ in the Theological state of the processed material. Thus, for viscous materials, casting, pressing, injection and coating are considered, while for viscoelastic polymers - injection, extrusion, calendering, rolling and possibly hewing. From the point of view of the shaped body, the shaped bodies of the invention can be made by casting, dipping, pressing, injection, extruding, calendering, deepening, bending, deep drawing, etc. These processing methods are known and require no further explanation. In principle, the above commentary, exemplified in relation to polyvinyl resin, also applies to other polymers.
The polyurethanes serving as the carrier are prepared in a manner known per se by the reaction of a polyisocyanate with high-molecular compounds containing at least two groups reactive to an isocyanate group, with the possible participation in the reaction of small-molecule chain extenders and / or monofunctional compounds interrupting chain growth .
Aliphatic, cycloaliphatic, araliphatic, aromatic and heterocyclic polyisocyanates, for example as described by W. Siefken in Liebig's Annalen der Chemie, 562, pages 75-136 are considered as starting materials in the polyurethane production process. Examples include: ethylene di / cyanate, tetramethylene 1,4-diisocyanate, 1,6-hexamethylene diisocyanate, 1,12, -diisocyanate-dodecane, 1,3-diisocyanate, cyclobutane, 1,3- and 1,4-diisocyanate cyclohexane as well as any mixtures of these compounds; 1-isocyanato-3,3,5-trimethyl-5-isocyanatomethyl-cyclohexane (see German Patent Application No. 202 785 and U.S. Patent No. 3,401,190), 2,4- and 2,6-dii / hexahydrotoluene cyanate as well any mixtures of these / compounds; 1,3- and / or 1,4-diisocyanate hexahydrophenylene, 2,4 and / or 4,4'-diisocyanateoperhydrodiphenylmethane, 1,3- and 1,4-phenylene diisocyanate, 2,4- and 2,6-dii / toluene cyanate as well as any mixtures of these compounds; 2,4'- and / or 4,4'-dh / diphenylmethane cyanoate 1,5-naphthylene diisocyanate, 4,4 ', 4-trii / triphenylmethane cyanate, polyphenylpolymethylene polyisocyanate obtained by condensation of aniline with formaldehyde and subsequent phosgenation in a manner ; presented e.g. in U. S. Patent Nos. 874 430 and 848 671; m- and p-isocyanatophenesulfonyl isocyanate, according to US Patent No. 3,454,606; perchlorinated aryl polyisocyanates such as disclosed in German Patent Application No. 1,157,601 and in US Patent No. 3,277,138; polyisocyanates containing carbodiimide groups such as, e.g., those described in German Patent No. 1 092; 007 and U.S. Patent No. 3,152,162; diisocyanates as described in U.S. Patent No. 3,492,330; polyisocyanates containing allophanate groups, e.g. described in United Kingdom Patent No. 994 890, in German Patent No. 761 626 and in Dutch Patent Application No. 7 102 524; polyisocyanates containing isocyanurate groups such as, e.g., those described in U.S. Patent No. 3,001 973, in German Patent Nos. 1 022 789, 1 222 067 and 1 027 394 as well as in German Laid-Open Nos. 1 929 034 and 2 004 048 ; polyisocyanates containing urethane groups such as e.g. described in German Patent No. 752,261 or in US Patent No. 3,394,164; polyisocyanates containing acylated urea groups according to German Patent No. 1 230 778; polyisocyanates containing biuret groups such as, e.g., those described in German Patent No. 1 101 394, in US Patent Nos. 3,124,605 and 3,201,372 as well as in W Britain No. 889 050; polyisocyanates produced by means of telomerization reactions such as e.g. described in the patent specification
190 280
United States of America No. 3,654,106; polyisocyanates containing ester groups such as, for example, those described in W. British Patent Nos. 965 474 and 1 072 956, in U.S. Patent No. 3,567,763 and in German Patent No. 1,231,688; reaction products of the above isocyanates with acetals according to German Patent No. 1 072 385 and polyisocyanates containing polymeric fatty acid residues according to US Patent No. 3,455,883.
It is also possible to use an isocyanate-containing distillation residue obtained in the course of industrial production of isocyanates, optionally dissolved in one or more of the aforementioned polyisocyanates. Any mixture of the above polyisocyanates can also be used. The preferred polyisocyanates are generally toluene diisocyanates and diisocyanate diphenylmethane.
The starting compounds for the production of polyurethanes are further compounds containing at least two isocyanate-reactive hydrogen atoms; as a rule, the molecular weight of these compounds is 400-10,000. Because these compounds, in addition to compounds containing amino, thiol or carboxyl groups, preferably include hydroxyhydroxyl compounds, especially with 2-8 hydroxyl groups, especially those with a molecular weight of 800-10 000, preferably 1000 - 6000. They are, for example, containing at least 2, usually 2-8, but preferably 2-4 hydroxyl groups, polyesters, polyethers, polytioether, polyacetals, polycarbonates and polyesteramides, the use of which in the production of uniform and blowing polyurethanes is known per se.
The polyesters containing hydroxyl groups considered here are, for example, reaction products with the participation of polycarboxylic acids, preferably dicarboxylic acids with the optional addition of tricarboxylic acids. Instead of free polycarboxylic acids, it is also possible to use suitable dolicarboxylic anhydrides or corresponding polycarboxylic acid esters with lower olkaholomi or mixtures thereof to make polyesters. Palicarboxylic acids may have the nature of aliphatic, -Olalaphosphate, aromatic and / or heterococcal, optionally substituted, e.g. halogen, and / or unsaturated. Examples include: succinic acid, adipic acid, corkic acid, azelaic acid, sebacic acid, phthalic acid, isophthalic acid, trimellitic acid, phthalic anhydride, tetrahydraftallavic anhydride, hexahodraftallavic acid anhydride, tetrachlorophthalic acid anhydride anhydride, endhydric acid anhydride , maleic anhydride, fumaric acid, dimers and trimer of fatty acids such as oleic acid, optionally in admixture with manameric fatty acids, terephthalic acid dimethyl ester and ethylene glycol bis-ester and tereital acid.
As pyrolysis salts, e.g. into account ethylene glycol, 1,2- and 1,3-propanediol, 1,4- and 2,3-butanadial, 1,6-hexαnadiol, 1,8-octanediol, neopentyl glycol, cyclohexanedimethanal (1,4-bis- hydroxymethyl-oxohexαn), 2-methyl-1,3-prapanedial, glycerin, trimethylpropane, 1,2,6-hexanetriol, 1,2,4-butαnatrial, trimethylol ethane, pentaerythritol, quinite, mannitol and sorbitol, methylglycosod, further diethylene glycol , triethylene glycol, tetraethylene glycol, polyoxyethylene glycols, dipropolene glycol, polyaxypropylene glycols, dibutylene glycol and palloxybutylene glycols. The polyesters may contain some proportion of carboxyl end groups. Polyesters obtained from lactones, e.g. from 8-caprolactone, or from rascarycarbaxol-b acids, e.g. from CO-hydroxybexanoic acid, may also be used.
Polyethers containing at least 2, usually 2-8, preferably 2-3 hydroxyl groups are considered as paline-drakyl alcohols. They are known as such and are produced e.g. as a result of polymerization of epoxy compounds themselves, such as ethylene oxide, propylene oxide, butylene oxide, tetrahydrofuran, styrene oxide or epi-blorahydrin, e.g. in the presence of BF 3, or by attaching these epoxy compounds, optionally in a mixture or in succession, to substrates starting materials containing reactive hydrogen atoms, such as water, alcohols, ammonia or amines, e.g. ethylene glycol, 1,3- or 1,2-propanadiol, trimethylolaprapαn, 4,4'-dihydroxy diphenyl propane, aniline, ethanolamine or ethylenediamine. Sucrose-based polyethers, e.g. those described in German Patent Applications Nos. 1,176,358 and 1 064 938, are also considered. Often preferred
190 280 are the polyethers in which the primary OH groups predominate (up to 90% by weight based on all OH groups present in the polyethers). Polyethers modified by polymerization of vinyl monomers are also suitable, e.g. formed by polymerization of styrene and acrylonitrile in the presence of a polyether (U.S. Patent Nos. 3,383,351 3 304 273, 3,523,093 and 3,110,695, and German Patent No. 1,152,536) as well as polybutadiene containing OH groups.
Polytioethers are especially condensation products of thiodiglycols themselves and / or with other glycols, dicarboxylic acids, formaldehyde, aminocarboxylic acids or amino alcohols. Depending on the type of co-agent, these products are mixed polioethers, polioetheroesters or polioeeeroeseroamides.
As polyacetals, for example, compounds derived from glycols such as diethylene glycol, triethylene glycol, 4,4-dioxoethoxydiphenyldimethylmethane or hexanediol and from formaldehyde are taken into account. Suitable polyacetals according to the invention can also be obtained by polymerizing cyclic acetals.
Polycarbonates containing hydroxyl groups include those types of polymers known as such which, for example, can be prepared by reaction of diols such as 1,3-propanediol, 1,4-butanediol and / or 1,6-hexanediol, diethylene glycol, triethylene glycol or tetraethylene glycol with diaryl carbonates, e.g. diphenyl carbonate or phosgene.
Polyesteramides and polyamides include, for example, condensates, mostly linear, obtained from saturated or unsaturated acids; polycarboxylic acids or their anhydrides and from saturated and unsaturated polyfunctional amino alcohols, diamines, polyamines and mixtures thereof.
It is also possible to use polyhydroxyl compounds containing urethane or urea groups as well as optionally modified polyols of natural origin such as castor oil, carbohydrates or starch. According to the invention, alkylene oxide attachment products for phenol-formaldehyde resins and urea-formaldehyde resins are also suitable. Representatives of this group of associations, e.g. described in the "High Polymers" series, volume XVI, "Polyurethans, Chemistry and Technology", editors of SaundersFrisch, Interacience Publishers, New York, London, vol. I, 1962, pages 32-44 and 44-54, and vol. II, 1964, pages 5-6 and 198-199, as well as in "Kunststoff-Handbuch", Volume VII, ViewegHochtlen, Carl-Hanser-Verlag, Munich, 1966, eg on pages 45-71.
Of course, it is also possible to use mixtures of the above compounds with compounds with a molecular weight of 400-10000 containing at least two isocyanate-reactive hydrogen atoms, e.g. mixtures with polyethers.
The optionally introduced starting compounds are also compounds with a molecular weight of 32-400 containing at least two isocyanate reactive hydrogen atoms. Also in this case are compounds containing hydroxyl groups and / or amino groups and / or thiol groups and / or carboxyl groups, preferably compounds serving as chain extenders or crosslinkers. These compounds usually contain from 2 to 8 isocyanate reactive hydrogen atoms, preferably 2 or 3 reactive hydrogen atoms. Examples of such compounds are: ethylene glycol, 1,2- and 1,3-propanediol, 1,4- and 2,3-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,8-octanediol, neopentyl glycol, 1,4- bis-hydroxymethyl-cyclohexane, 2-methyl-1,3-propanediol, glycerin, trimethylolpropane, 1,2,6-hexaneeriol, trimethylol ethane, pentaeryerye, quinite, mannitol and sorbitol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyoxyethylene glycols molecular weight up to 400, dipropylene glycol, polyoxy propylene glycols with molecular weight up to 400, bibutidene glycol, polyoxybutylene glycols with molecular weight up to 400, 4,4-dihydroxy diphenylpropane, dihydroxymethyl hydroquinone, ethanolamine, diethanolamine, triethanolamine, 3-aminopropanol, 1,3-diaminamine mercapto-3-aminopropane, 4-hydroxy-phthalic acid, aminophthalic acid, succinic acid, adipic acid, hydrazine, N, N'dimethylhydrazine, 4,4'-diaminodiphenylmethane, toluene diamine, methylene-bis-chloroaniline, methylene-bis-anthranilic acid esters, diaminobenzoic acid esters and isomeric chlorophenylenediamines. Also in this case different mixtures can be used
190 280 compounds with a molecular weight of 32-400 containing at least two isocyanate-reactive hydrogen atoms.
However, it is also possible to use polyhydroxyl compounds in which high-molecular polyadducts or polycondensates exist in dissolved form as suspensions with a high degree of dispersion. Modified polyhydroxyl compounds of this type are prepared in such a way that polyaddition reaction (e.g. reaction of polyisocyanate with a compound containing amino functional groups) or polycondensation (e.g. formaldehyde with phenol and / or amine ") is carried out directly in situ in the environment of the abovementioned hydroxyl group containing compounds. These methods are described, for example, in German Patent Applications Nos. 168 075 and 1 260 142 and in German Laid-Open Nos. 2 324 134, 2 423 984, 2 512 385, 2 513 815, 2 550 797, 550 833 and 2 550 862. As described in US Patent No. 3,869,613 or German Patent Laid-open No. 2,550,860, it is also possible to mix the finished aqueous polymer suspension with a polyhydroxy compound and subsequently remove water from the mixture.
When selecting the high molecular polyol component for the polyurethane production process, it is important to ensure that the finished polyurethane does not swell in water. For this reason, the use of excess polyhydroxy compound containing ethylene oxide units (polyether or polyester polyoxyethylene glycol based on diethylene glycol or triethylene glycol as a diol component) must be avoided.
Thermoplastic elastomers are particularly preferably used for making molded parts. These are materials containing in the thermoplastic polymer phase a physically mixed or chemically bonded elastomer phase. A distinction is made here between polymer mixtures in which the elastomer phase forms part of the polymer backbone. Due to the construction of a thermoplastic elastomer, there are rigid and flexible areas side by side. The rigid areas form a crystal lattice or continuous phase; intermediate spaces in these structures are filled by elastomer segments. This construction means that the materials in question are rubber-like.
Thermoplastic elastomers can be divided into 5 main groups:
1. copolyesters
2. Block poly (ether-amides) (PEBA)
3. Thermoplastic polyurethanes (TPU)
4. Thermoplastic polyolefins (TPO)
5. Block styrene copolymers
Suitable copolyesters (polyester elastomers with a segmental structure) are, for example, products built of repeated repeating short chain ester units and long chain ester units linked together by ester bonds. The content of short chain ester units in the copolyester is about 15-65% by weight. They are described in formula 30, in which
R is a divalent dicarboxylic acid residue with a molecular weight not exceeding about 350,
G is a divalent organic diol residue with a molecular weight not exceeding about 250.
The content of long chain ester units in the copolyester is about 35-85% by weight. They are described in formula 31, in which
R is a divalent dicarboxylic acid residue with a molecular weight not exceeding about 350,
G is a divalent long chain glycol residue with an average molecular weight of about 350-6000.
The co-polyesters used according to the invention are obtained in such a way that a) one or several dicarboxylic acids are polymerized together, b) one or several linear long chain glycols and c) one or several low molecular weight diols. As dicarboxylic acids, aromatic, aliphatic or cycloaliphatic dicarboxylic acids can be used to prepare copolyesters. Aromatic acids are preferred dicarboxylic acids
190 280 containing 8-16 C atoms, especially phenylenedicarboxylic acids such as phthalic acid, terephthalic acid and isophthalic acid.
Small molecule: diols that form short-chain ester units in copolyesters are classified as acyclic, alicyclic and aromatic dihydroxy compounds. Preferred diols contain 2-15 C atoms; they are, for example, glycols: ethylene, propylene, tetramethylene, isobutylene, pentamethylene, 2,2-dimethyltrimethylene, hexamethylene and decamethylene as well as dihydroxycyclohexane, cyclohexanedimethanol, resorcinol, hydroquinone and the like. The group of bisphenols used for this purpose includes bis- (p-hydroxy) diphenyl, bis- (p-hydroxy-phenyl) -methane, bis- (p-hydroxyphenyl) -ethane and bis- (p-hydroxyphenyl) -propane .
The long chain glycols forming the flexible copolyester segments preferably have a molecular weight in the range of about 600-3000. These include polyoxyalkylene glycols with alkylene groups containing 2-9 carbon atoms. Glycolester based on dicarboxylic polyoxyalkylene acids as well as polyester glycols can also be used as long chain glycols. Long chain glycols also include polyphormals produced by reacting glycols with formaldehyde. Polytioether glycols are also useful. Satisfactory long-chain polymeric glycols are glycols based on polybutadiene, polyisoprene or mixtures of these polymers, as well as saturated hydrogenation products of these materials.
Methods for making said copolyesters are known from German Patent Application Nos. 2,239,271, 2,213,128 and 2,449,343 and US Patent No. 3,032,192. Suitable copolyesters exist, e.g. market under the brand names ®Hytrel from Du Pont, ®Pelpren from Toyobo, ®Amitel from Akzo, ®Ectel from Eastman Kodak and ®Riteflex from Hoechat.
Suitable block polyetheramides) are, for example, those whose polymer chain is composed of repeating units corresponding to formula 32 in which
A is a polyamide chain with two carboxy-terminal groups after rejecting these groups,
B is a polyoxyalkylene glycol chain with OH end groups after rejecting these groups and n is the number of units forming the polymer chain.
The end groups are preferably OH groups or residues of polymerization interrupting compounds.
Dicarboxylic acid polyamides with carboxyl end groups are obtained in known manner, e.g. by polycondensation of one or several lactams or / and one or several amino acids further by polycondensation of one dicarboxylic acid with one diamine in the presence of an excess of organic dicarboxylic acid, preferably with terminal carboxyl groups. Such carboxylic acids enter the polyamide chain during polycondensation, joining in particular to its chamois, thanks to which polyamide α, ω-dicarboxylic acid can be obtained. In addition, said dicarboxylic acids act as a chain stopper because they are introduced in excess.
The polyamide can be prepared from lactams and / or amino acids with a hydrocarbon chain containing 4-14 C atoms, such as e.g. caprolactam, enantolactam, dodecanolactam, undecanolactam, decanolactam, 11-aminoundecanoic acid or 12-aminododecanoic acid.
As examples of polyamides resulting from the polycondensation of one dicarboxylic acid with one diamine, the condensation products of hexamethylenediamine with adipic acid, azelaic acid, sebacic acid or 1,12-dodecane dicarboxylic acid, as well as the products of nonamethylenediamine with adipic acid can be cited.
As dicarboxylic acids used for the synthesis of polyamides, i.e. on the one hand serving to introduce a carboxyl group on both ends of the polyamide chain, and on the other hand being agents that interrupt the chain growth, dicarboxylic acids containing 4-20 C atoms are considered, especially alkane dicarboxylic acids such as succinic, adipic, corkic, azelaic, sebacic, undecanedicarboxylic acid
190 280 or dodecanedicarboxylic as well as cycloaliphatic or aromatic dicarboxylic acids such as terephthalic, isophthalic or cyclohexane-1,4-dicarboxylic acid.
Polyoxyalkylene glycols with OH end groups are unbranched or branched compounds and contain an alkylene residue having at least 2 C atoms. In particular, they are polyoxyethylene, polyoxypropylene and polyoxytetramethylene glycols and their copolymers. The average molecular weight of these polyoxyalkylene glycols with OH end groups can be in a wide range; Preferably it is 100-6000, especially 200-3000 The mass fraction of polyoxyalkylene glycols is 5-85%, preferably 10-50%, based on the total mass of polyoxyalkylene glycols and polyamides of the dicarboxylic acid type used to make PEBA polymers. The method of producing such PEBA polymers is known from French Patent No. 7,418,913 (Laid-Open No. 2,273,021), German Laid-Open Descriptions No. 2 802 989, 2 837 687, 2 523 991, 2 712 987 or 2 716 004 and from European Patent No. 0 095 893.
Particularly useful are PEBA polymers that, unlike those described above, have a statistical structure. They are made of a mixture consisting of:
1. one or more compounds capable of forming polyamides from the group of GOamino acids, carboxylic acids or lactams with at least 10 carbon atoms,
2. one α, ω-dihydroxy polyoxyalkylene glycol,
3. at least one organic dicarboxylic acid in mass ratios of 1: (2 + 3) from 30:70 to 98; 2, wherein in the 2 + 3 system the hydroxyl and carboxylic groups are present in an equivalent amount. This synthesis is carried out in the presence of 2-30% by weight of water based on compounds capable of forming polyamides belonging to group 1. The system is heated under its own pressure at a temperature of 23 ° C - 30 ° C and then, after removing the water, it is heated at a temperature of 250 ° C - 280 ° C in the absence of oxygen at atmospheric pressure or reduced pressure. Such preferably useful PEBA polymers are e.g. described in German Patent Laid-open No. 2,712,987. Useful and preferably useful PEBA polymers are e.g. commercially available under the trade names ®Pebax of the company Atochem, ®Vestamid of the company Hols AG, ®Grilamid of the company ENS-Chemie and ®Kellaflex of the company DSM.
The content of active substance in the shaped bodies is 1-20% by weight, preferably 5-20% by weight), particularly preferably about 10% by weight. In the case of a collar, a preferred concentration of active substance is 1-15%, in the case of a medallion, tags and ear tags a concentration of 5-2056 is preferred, and in the case of foil and adhesive strips a concentration of 0.1-5% is preferred.
The active substance in preparations and moldings may be present in a mixture with a synergistic substance or with another active substance. The active substances include insecticides such as phosphorus-containing compounds, i.e. phosphoric acid or phosphonic acid esters, natural or synthetic pyrethroids, carbamates, amidines, juvenile hormones and synthetic active substances of typuvenoids.
The group of esters of phosphoric acid or phosphonic acid includes: O-8-quinolyl-O-ethyl phenylthiophosphate (quinothiophos),
O, O-3-chloro-4-methyl-7-coumarinyl O-diethylthiophosphate (coumaphos), O-phenylglyoxylnitrile-oxime oxothiophosphate ) O, O-O-diethyl phosphorothioate O-4-bromo-2,5-dichlorophenyl (ethylbromophos), O, O, O ', O'-tetraethyl di (phosphorodithioate) S, S'-methylene (ethion), S, S -bis (O, O-diethyl phosphorodithioate) 2,3-p-dioxanedithiol, 2-chloro -1- (2,4-dichlorophenyl) vinyl diethyl phosphate (chlorfenwinfos), O, O-3-methyl-4-methylthiophenyl O-dimethylthiophosphate (fention).
Carbamates include:
2-isopropoxyphenyl methylcarbamate (propoxur),
N-methylcarbamate 1-naphthyl (carbaryl).
Synthetic pyrethroids include compounds of the formula 33 in which
R<sup>1</sup> and R<sup>2</sup> are halogen, optionally substituted with halogen, optionally substituted with phenyl;
190 280
R<sup>3</sup> represents a hydrogen atom or a CN group;
R<sup>4</sup> is hydrogen or halogen;
R<sup>5</sup> is hydrogen or halogen.
Synthetic pyrethroids of formula 33 in which are preferred
R<sup>1</sup> is halogen, especially fluorine, chlorine, bromine;
R represents a halogen atom, especially fluorine, chlorine, bromine, trihalomethyl, phenyl, chlorophenyl;
R<sup>3</sup> represents a hydrogen atom or a CN group;
R4 is hydrogen or fluoro;
R5 is hydrogen.
Synthetic pyrethroids of the formula 33 in which they are preferred are particularly preferred
R 1 is chlorine;
R represents a chlorine atom, a trifluoromethyl group, a p-chlorophenyl group;
R 3 represents a CN group;
R4 is hydrogen or fluoro;
R5 is hydrogen.
Most preferred are compounds of formula 33 in which
R 1 is chlorine;
R<sup>2</sup> is a chlorine atom or a p-chlorophenyl group
R 3 represents a CN group;
R<sup>4</sup>is a fluorine atom in position 4
R5 is hydrogen.
In particular, the following are mentioned:
3- [2- (4-Chloro-phenyl) -2-chlorovinyl] -2,2-dimethyl-cyclopropanecarbcksylic acid (α-cyano-4-fluoro-3-phenoxy) -benzyl ester (flumetry), α-cyano ester ( 2,2-dimethyl-3- (2,2-dichloro-methyl) -cyclopropanecarboxylic acid (cyfluthrin) and its enantiomers and stereomers, (±) -cis, trans-3- (2, fluoro-3-phenoxy) -benzyl acid. Α-cyano-3-phenoxybenzyl 2-dibromovinyl) -2,2-dimethylcyclopropyl α-cyano-3-phenoxybenzyl carboxylate (deltamethrin), 2,2-dimethyl-3- (2,2-dichloro-yl-yl) -cyclopropane-carboxylic acid α-cyano-3-phenoxybenzyl ester (c-ypenetrietine), (±) -cis, ans'ans-3- ( 2,2-dic ^ hococγinylo)) 2,2-dinmtylocykloc><sup>r</sup>3-phenoxybenzyl opa-carboxylate (permethrin), α- (p-Cl-phenyl) -isovaleric acid α-cyano-3-phenoxy-benzyl ester (fenvalerate),
2- (2-chloro-α, α, α-trifluoro-p-toluidine) -3-methylbutyrate-2-cyano-3-phenoxybenzyl (fluvalinate).
Amidines include:
3-methyl-2- (2,4-dimethyl-phenylimin) -thiazoline,
2- (4-chlorc-2-metylofenyloiminoy-3-methylthiazolidin.
2- (4-chlorc-2-metylcfenyloimino) -3- (izcbutyl-1-enyl) -tiazolidynę.
1,5-bis- (2,4-dimethylphenyl) -3-methyl-1,3,5-triazapenta-1,4-diene (amitraz).
Juvenile hormones as well as juvenile hormone substances include substituted diaryl ethers, benzoylureas and triazine derivatives. Juvenile hormones as well as juvenile hormone substances include, in particular, compounds of formulas 34-40.
The group of substituted diaryl ethers includes, in particular, substituted alkoxydiphenyl ethers or alkoxydiphenyl methane of formula 4 in which
R i is hydrogen, halogen, alkyl, alkoxy, alkylthio, haloalkyl, chloroalkoxy, chloroalkylthio, dioxoalkylene, dioxohaloalkylene, CN, NO2, alkenyl, alkynyl, alkoxyalkyl, alkoxyalkoxy, hydroxyalkoxy;
R2 has the meaning given with respect to R1
R 3 is as defined with respect to R 1;
R4 represents a hydrogen atom, an alkyl group, a haloalkyl group or a halogen atom;
190 280
R<sup>5</sup> has the meaning given with respect to R<sup>4</sup>;
Het is an optionally substituted heteroaryl group which is not bonded via a heteroatom to another group;
X and Y are each independently -O-, -S-;
Z is -O-, -S-, -CH2-, -CHCHr, -C (CH3) 2-;
m and n are each independently 0,1, 2, 3, where their sum is or exceeds 2.
Particularly preferred are compounds of formula 4 in which
R1 is hydrogen, methyl, trifluoromethyl, methoxy, trifluoromethoxy, fluoro, chloro;
R2 is hydrogen;
-J *
R is hydrogen, fluoro, chloro, methyl; R4 represents a hydrogen atom or a methyl group;
R5 is methyl, ethyl, trifluoromethyl or hydrogen;
Het is a pyridyl or pyridazinyl group, which groups are optionally substituted by fluoro, chloro, methyl, NO 2, methoxy, methyl mercaptan;
X is O;
Y is O;
Z is O, -CH2- or -C (CH3) 2-; m is 1; n means 1.
In particular, the compounds of formula 41 listed in Table 1 are listed.
Table 1. Compounds of formula 41
<td>R<sup>1</sup></td><td>R<sup>2</sup></td><td>R<sup>5</sup></td><td>R<sup>6</sup></td><td>FROM</td>
<td>H</td><td>H</td><td>ch<sub>3</sub></td><td>H</td><td> 0</td>
<td>H</td><td>H</td><td>CH3</td><td>2-Cl</td><td> 0</td>
<td>5-F</td><td>H</td><td>CH3</td><td>H</td><td> 0</td>
<td>H</td><td>H</td><td>GF3</td><td>H</td><td> 0</td>
<td>H</td><td>H</td><td>C2H5</td><td>H</td><td> 0</td>
<td>H</td><td>H</td><td>H</td><td>H</td><td> 0</td>
<td>H</td><td>H</td><td>CH3</td><td>H</td><td>CH2</td>
<td>H</td><td>H</td><td>CH3</td><td>H</td><td>C (CH3) 2</td>
Benzoyl ureas include compounds of the formula 5 in which R1 is a halogen atom;
R2 is hydrogen or halogen;
R3 is hydrogen, halogen or C1-C4 alkyl;
R<sup>4</sup> is halogen, group 1-5-halogen-C1-C \<sub>t</sub>alkyl,
C1-C4-alkoxy, 1-5-halogeno-C<sub>r</sub>C4-alkoxy, C1-C4-alkylthio, 1-5-halogen-C1-C4-alkylthio, phenoxy or pyridyloxy, which groups can optionally be substituted with halogen, C-C6-alkyl, 1-5-halogen-C1- C4-alkyl, C1 - ('(- (alkoxy, 1-5-halogen-C1-C6-alkoxy, C1-C4-alkylthio, 1-5-halogen-C1-C4-alkylthio.
Mentioned in particular are the compounds of formula 42 in Table 2.
190 280
Table 2 Compounds of formula 42
<td>R '</td><td>R<sup>2</sup></td><td>R<sup>4</sup></td>
<td>H</td><td>cl</td><td>CF3</td>
<td>cl</td><td>cl</td><td>cf<sub>3</sub></td>
<td>F</td><td>F</td><td>cf<sub>3</sub></td>
<td>H</td><td>F</td><td>cf<sub>3</sub></td>
<td>H</td><td>cl</td><td>SCF 3</td>
<td>F</td><td>F</td><td>SCF 3</td>
<td>H</td><td>F</td><td>SCF 3</td>
<td>H</td><td>cl</td><td>OCF 3</td>
<td>F</td><td>F</td><td>OCF 3</td>
<td>H</td><td>F</td><td>OCF 3</td>
<td>F</td><td>F</td><td>formula 43</td>
<td>F</td><td>F</td><td>formula 44</td>
<td>F</td><td>F</td><td>formula 44</td>
Triazines include compounds of the formula 6 in which
R<sup>1</sup> is a cyclopropyl or isopropyl group;
R<sup>2</sup> represents a hydrogen atom, a halogen atom, a G-C12-alkylkyl) canonyl group. cyclopropylcarbonyl, C1-C12-alkylcarbamoyl, C1-C12-alkylthiocarbamoyl or C2-C6alkenylcarbamoyl; and
R<sup>3</sup> is hydrogen, CC ^ alkyl, cyclopropyl, C2-C6 alkenyl, C1Ci<sub>2</sub>-alkylcarbonyl, cyclopropylcarbonyl, C 1 -C 12 -alkylcarbamoyl, C 1 -C 13 -alkylthiocarbamoyl or C 2 -C 6 -alkenylcarbamoyl as well as those acid addition salts thereof that are non-toxic to warm-blooded animals.
In particular, the compounds listed in Table 3 are listed.
Table 3
Compounds of formula 6
<td>R1</td><td>R2</td><td>R3</td>
<td> 1</td><td> 2</td><td> 3</td>
<td>cyclopropyl</td><td>H</td><td>H</td>
<td>cyclopropyl</td><td>H</td><td>ch<sub>3</sub></td>
<td>cyclopropyl</td><td>H</td><td>C 2 H<sub>5</sub></td>
<td>cyclopropyl</td><td>H</td><td>C3Hv-n</td>
<td>cyclopropyl</td><td>H</td><td>N-C4H9</td>
<td>cyclopropyl</td><td>H</td><td><sup>C</sup>5<sup>H</sup>1-<sup>n</sup></td>
<td>cyclopropyl</td><td>H</td><td><sup>C</sup>6<sup>H</sup>13-<sup>n</sup></td>
190 280
Table 3 continued
<td> 1</td><td> 2</td><td> 3</td>
<td>cyklaprapol</td><td>H</td><td><sup>C</sup>7<sup>H</sup>15<sup>-n</sup></td>
<td>cyclopropyl,</td><td>H</td><td>CSH | n-7</td>
<td>cyclopropyl</td><td>H</td><td>C] 2<sup>-</sup>H25<sup>-</sup>n</td>
<td>coklaprapol</td><td>H</td><td>C-n -CąHę</td>
<td>coklapropol</td><td>H</td><td>CH<sub>2</sub>CH (CH<sub>3</sub>) C<sub>2</sub>H5</td>
<td>coklaprapol</td><td>H</td><td>ch<sub>2</sub>= CH<sub>2</sub></td>
<td>cyclopropyl</td><td>G1</td><td>C<sub>2</sub>H5</td>
<td>coklapropol</td><td>cl</td><td><sup>C</sup>6<sup>H</sup>un</td>
<td>cyklapropol</td><td>cl</td><td>CgHp-n</td>
<td>cyclopropyl</td><td> 01</td><td>N-C12H25</td>
<td>cyclopropyl</td><td>H</td><td>coklapropol</td>
<td>cyclopropyl</td><td>H</td><td>COCH3</td>
<td>coklapropol</td><td>H</td><td>COCH3 · HCl</td>
<td>cyclopropyl</td><td>H</td><td>COC2H5 · HCl</td>
<td>cyclopropyl</td><td>H</td><td>COC2H5</td>
<td>cyklapropol</td><td>H</td><td>COC3H7-n</td>
<td>coklapropol</td><td>H</td><td>COC3H7-1</td>
<td>cyklapropol</td><td>H</td><td>COC<sub>4</sub>H<sub>9</sub>-t · HCl</td>
<td>Isopropyl-cantaloupes</td><td>H</td><td>COCąH ^ n</td>
<td>cyclopropyl</td><td>H</td><td>COCćHu-n</td>
<td>cyclopropyl</td><td>H</td><td>COC11-H<sub>23</sub>-n</td>
<td>coklapropol</td><td>COCH,</td><td>COC2H5</td>
<td>cyklapropol</td><td>COCsH7-n</td><td>COC<sub>6</sub>H13-n</td>
<td>coklapropol</td><td>COCH3</td><td>COC3H7-n</td>
<td>cyclopropyl</td><td>COC<sub>2</sub>H<sub>5</sub></td><td>COC3H7-n</td>
<td>coklapropol</td><td>H</td><td>COcoklapropol</td>
<td>cyclopropyl</td><td>COcyklopropyl</td><td>COcyklopropyl</td>
<td>coklapropol</td><td>coch<sub>3</sub></td><td>COCH3</td>
<td>isopropyl</td><td>H</td><td>H</td>
<td>isopropyl</td><td>H</td><td>COCH3</td>
<td>isopropyl</td><td>H</td><td>COC3H7-n</td>
<td>coklapropol</td><td>H</td><td>CONHCH3</td>
<td>cyklapropol</td><td>H</td><td>CONHC3H7-1</td>
<td>cyklapropol</td><td>CONHCH<sub>3</sub></td><td>CONHCH3</td>
190 280
Table 3 continued
<td> 1</td><td> 2</td><td> 3</td>
<td>cyclopropyl</td><td>H</td><td>SCNHCH3</td>
<td>cyclopropyl</td><td>H</td><td>CONHCH2CH = CH2</td>
<td>cyclopropyl</td><td>CONHCH<sub>2</sub>CH = CH<sub>2</sub></td><td>CONHC2CH = CH2</td>
<td>cyclopropyl</td><td>csnhch<sub>3</sub></td><td>CSNHCH3</td>
Active substances with common names propoksur, cyfluthrin, flumethrin, pyriproxyfen, methoprene, diazinon, amitraz, fention and levamisole are particularly preferred.
Fittings can also contain typical additives introduced into plastics. Typical additives are, for example, pigments, stabilizers, anti-caking agents, release agents, agents to facilitate removal of the mold from the mold.
In the following examples, the active compound uses 1 - [(6-chloro-3-pyridinylmethyl] -N-nitro-2-imidazolidinium compound, commonly known as imidacloprid.
Example 1
SC (suspension concentrate) preparation:
imidacloprid - 368 g block copolymer ethylene oxide / propylene oxide as an emulsifier - 35 g condensate of ditolyl ether sulfonate with formaldehyde as an emulsifier - 12 g water-soluble poly (vinyl alcohol) - 3.5 g
NHąCl - 58.0 g urea - 116.0g
37% aqueous hydrochloric acid solution - 1.2 g xanthan gum - 4.5 g and distilled water - 560.5 g
Example II
Preparation WP (powder forming a dispersion):
imidacloprid - 25.0 g sodium diisabutylnaphthalene sulfonate - 1.0 g calcium salt of n-dodecylbenzylsulfonic acid - 10.0 g alkylaryl polyglycol ether containing highly finely divided silica - 12.0 g dithilyl ether sulfonate condensate with formaldehyde as emulsifier - 3.0 g
Baysilon - E, silicone antifoaming agent from Bayer AG - 2.0 g high-grade silicon dioxide - 2.0 g and kaolin - 45.0 g
Example III
SL (water-soluble concentrate):
imidacloprid - 18.3 g a neutral emulsifier based on an alkyl aryl polyglycol ether - 2.5 g sodium diisoctyl sulfonosuccinic acid ester - 3.5 g dimethyl sulfoxide - 38.4 g and
2-propanol - 37.5 g
Example IV
SL (water-soluble concentrate);
imidacloprid - 185.0 g sodium diisoctyl sulfosuccinic acid ester - 5.0 g and dimethyl sulfoxide - 76.5 g mixed with 100 g of shampoo with the following composition:
44.4% by weight Marlon AT 50, i.e. the triethanolamine salt and alkyl benzene sulfonic acid from H uls AG,
190 280
11.1% by weight Marlon A 350, i.e. the sodium salt of alkyl benzene sulfonic acid from Huls AG,
3.0% by weight condensation product of oleic acid with diethanolamine from Huls
AG and
41.5% by weight polyoxyethylene glycol
Example V
Spray preparation containing:
imidacloprid - 2.0 g dimethyl sulfoxide - 10.0 g
2-propanol - 35.0 g and acetone - ^^ 0 g
Example VI
Pouring agent for imidacloprid - 20.3 g poly (vinyl alcohol) - 1.8 g block copolymer ethylene oxide / propylene oxide - 1.8 g xanthan gum - 0.26 g glycerin - 9.0 g and distilled water - 59, 2 g
Example VII
Composition:
imidacloprid- 10.00 g di-n-butyl adipate - 21.10 g diethylhexyl phthalate - 9.10 g epoxidized soybean oil - 2.30 g stearic acid - 0.80 g poly (vinyl chloride) (PVC) - 56.70 g
Production method:
The homogeneous mixture of imidacloprid with PVC is moistened in the mixer with a composition consisting of di-n-butyl adipate, diethylhexyl phthalate and epoxidized soybean oil. The whole is mixed until homogeneous. The softening process of the PVG softener composition is promoted by heating, e.g. by increasing the number of revolutions of the stirrer. Then, after uniform distribution in the stearic acid system, injection-molded collars are formed from the mixture.
Example VIII
Composition:
imidacloprid- 10.00 g epoxidized soybean oil - 2.30 g stearic acid - 0.80 g tributyl acetylearitrate - 30.20 g
PVC - 56.70 g
Production method:
A composition composed of tributyl acetyl citrate and epoxidized sodium oil is mixed in a mixer until a homogeneous mixture with imidacloprid and FVC is obtained. Heating while mixing promotes the homogenization of the composition of PVC softeners. The whole is mixed until homogeneous. Dog mixes are typically extruded from the mixture.
Example IX
Composition:
imidacloprid - 20.00 g epoxidized soybean oil - 2.30 g stearic acid - 0.80 g acetyl citrate tributyl - 30.20 g
PVC - 56.70 g
Production method: the procedure is as in Example VIII.
190 280
Example X
Composition:
imidacloprid - 7.50 g epoxidized soybean oil - 10.00 g stearic acid - 0.80 g acetyl citrate tributyl citrate - 15.00 g
PVC - 66.70 g
Production method: the procedure is as in Example VIII.
Example XI
Composition:
imidacloprid- 10.00 g epoxidized soybean oil - 2.30 g stearic acid - 0.80 g triacetin - H, 00g
PVC- 7 ^, ^ 0g
Production method
The composition consisting of triacetin and epoxidized soybean oil is mixed in a PVC and imidacloprid mixer until a homogeneous system is obtained. The homogenization and softening of PVC is conducive to heating, e.g. by increasing the speed of the stirrer. After unifying mixing with stearic acid, the plates are extruded from the whole, from which the medallions are cut (tags for the collar).
Example XII
Composition:
imidacloprid - 5.00 g poly (ether-amide) block (Pebax®) - 94.50 g
Production method:
The active substance is spread in the potty using an intensive mixer and dog collars are formed from the mixture by injection.
Example XIII
Composition:
imidacloprid - 10.00 g moderate chain triglyceride - 11.00 g high fragmentation silicon dioxide - 0.50 g poly (ether-amide) block (Pebax®) - 74.50 g
Production method:
A homogeneous mixture of moderate chain triglyceride, imidacloprid and block poly (ether-amide) is prepared in the mixer. In this process, heating promotes homogenization of moderate chain triglyceride with the block poly (ether amide). To improve flowability, silicon dioxide with a high degree of fragmentation is homogeneously distributed in the mixture prior to extrusion. The whole is extruded plates, from which medallions are cut (collar tags).
Example XIV
Composition:
imidacloprid- 10.00 g styrene / butylene block copolymer (Thermoplast®) - 90.00 g
Production method:
The active substance is spread in the carrier by means of an intensive mixer and collars are formed from the mixture by injection.
Example XV
Composition:
imidacloprid - 5.00 g copolyester (Hytrel®) - 95.00 g
Production method:
Dog collars are typically extruded from the mixture.
190 280
Example XVI
Composition:
imidacloprid - 10.00 g poly (ether-amide) block (Pebax®) - 90.100 g
Production method:
The homogeneous mixture is extruded in the extruder plates from which the medallions (collar tags) are punched.
Example XVII
Composition:
imidacloprid - 10.00 g moderate chain triglyceride - 30.00 g high fragmentation silicon dioxide - 0.50 g poly (ether-amide) block (Pebax®) - 59.50 g
Production method: the procedure is as in Example 13.
Example XVIII ml of the SC composition of Example 1 in the form of a pour-on solution is spread on the shoulders of a dog infected with 200 fleas. The experimental animal can immediately be released from adult fleas. The inventive method results in 100% flea mortality.
EXAMPLE 19 Example of use ml of the composition of Example 1 is diluted with 1 L of water and dogs infected with fleas are sprayed with this solution. Table 4 shows the results obtained.
Table 4
<td rowspan="2">Time cycle, days</td><td colspan="2">Number of fleas per dog</td><td rowspan="2">% efficiency</td>
<td>not sprayed</td><td>sprayed</td>
<td>-1 Infection with 100 fleas</td><td></td><td></td><td></td>
<td>0 Sprinkling and counting</td><td> 30</td><td> 0</td><td> 100</td>
<td>5, 8 Infection with 100 fleas</td><td></td><td></td><td></td>
<td>9 Counting</td><td> 56</td><td> 0</td><td> 100</td>
<td>15 Infection with 100 fleas</td><td></td><td></td><td></td>
<td>16 Counting</td><td> 76</td><td> 0</td><td> 100</td>
<td>19 Infection with 100 fleas (non-sprinkled animals) 250 flea infection (sprinkled animals)</td><td></td><td></td><td></td>
<td>20 Counting</td><td> 39</td><td> 0</td><td> 100</td>
<td>26 Infection with 100 fleas</td><td></td><td></td><td></td>
<td>27 Counting</td><td> 43</td><td> 0</td><td> 100</td>
Example XX An example of the use of ml of the solution according to example I is spread over the shoulders of the dog. After 216 days after subjecting the dog to the solution, the animal is infected with 200 fleas, and on the third and seventh days after the solution is distributed, surviving fleas are counted on the dog. Not a single living flea can be found, so the efficiency is 100%.
190 280
Subst.
Subst
aryl,
heteroaryl
MODEL 2a
heteroaryl
MODEL 2a 'you
<img file="PL190280B1_D0001.tif" />
<img file="PL190280B1_D0002.tif" />
(CH<sub>2</sub>)<sub>n</sub>-N<sub>x</sub> /
C
II (Z) (A) (A) (ch<sub>2</sub>) '- n<sub>s</sub> / (Z) c
II
Ε-Χ
Walkthrough level 2a c
II
190 280
Subst //
ME) 'rT ^ JZ)
II
Ε-Χ
PATTERN
R<sup>4</sup> R<sup>5</sup>
Y- (CH)<sub>n</sub><sup>_</sup> (CH)<sub>m</sub>~ χ- H et
<img file="PL190280B1_D0003.tif" />
<img file="PL190280B1_D0004.tif" />
<img file="PL190280B1_D0005.tif" />
R<sup>3</sup>
R<sup>4</sup>
NH-R-)
Ν<sup>Λ</sup>Ν a<sub>m</sub>and
R<sub>2</sub>-NH N NH-R3 MODEL 6
190 280
I = formula_7
<img file="PL190280B1_D0006.tif" />
MODEL 8
CH<sub>3</sub><sup>c</sup>'V ^ CH2-<sup>N</sup>ENH<sub>2</sub> n-no<sub>2</sub>
MODEL 9
190 280
<img file="PL190280B1_D0007.tif" />
MODEL 10
cl
<img file="PL190280B1_D0008.tif" />
en<sub>3</sub> n n<sub>3</sub>
J
IK
NO2
Walkthrough level 11
<img file="PL190280B1_D0009.tif" />
MODEL 12
190 280
Cl © JhCH<sub>2</sub>-N NH <sup>N</sup> lV
CN
Walkthrough level 14
<img file="PL190280B1_D0010.tif" />
NHCH3 n-no<sub>2</sub>
Walkthrough level 15
Cl (© CHc-N ^ SN = / <sup>from</sup> V
CN
Walkthrough level 16
<img file="PL190280B1_D0011.tif" />
N NH
Y
CH
N0<sub>2</sub>
Walkthrough level 18
190 280
<img file="PL190280B1_D0012.tif" />
<img file="PL190280B1_D0013.tif" />
ę<sup>H</sup>3
CHg-Ń ^ / N (C ch-no<sub>2</sub>
Walkthrough level 19 <sup>α</sup>Ο<sup>Ν</sup>©<sup>Η</sup>
CH
N0<sub>2 </sub>Walkthrough level 20<sup>H</sup>3
Cl—— CH<sub>2</sub>-NN (CH)<sub>2</sub><sup>N</sup> n-no<sub>2</sub>
Walkthrough level 21
190 280 ares<sup>H</sup>3
Cl ^<sup>r</sup>y-CH<sub>2</sub>-N-C-CH<sub>3</sub>
N = + ii © N
Walkthrough level 22
<img file="PL190280B1_D0014.tif" />
Walkthrough level 23
<img file="PL190280B1_D0015.tif" />
Walkthrough level 24
190 280 c
<img file="PL190280B1_D0016.tif" />
ch<sub>3</sub> ch<sub>3</sub><sup>—</sup> N (- ^ N ~ CH<sub>3</sub>
Walkthrough level 25
<img file="PL190280B1_D0017.tif" />
Walkthrough level 27
CL
CH2-N
<img file="PL190280B1_D0018.tif" />
Walkthrough level 29
-CRCOD-OII II oo
Walkthrough level 30
190 280
- CRCOG-OII II O 0
Walkthrough level 31
-CACOB-OII II
Walkthrough level 32
R2<sup>></sup>
<img file="PL190280B1_D0019.tif" />
Walkthrough level 33
190 280
<img file="PL190280B1_D0020.tif" />
IZO-H7C3
<img file="PL190280B1_D0021.tif" />
Walkthrough level 35
<img file="PL190280B1_D0022.tif" />
Walkthrough level 36
190 280 ch<sub>3</sub> ch<sub>3</sub> ch<sub>3</sub> about
Walkthrough level 37
CH<sub>3</sub> ch<sub>3</sub> ch<sub>3</sub>oh<sub>3 </sub>h<sub>3</sub>c<sup>> L</sup>^^^<sup>X</sup>-<sup>AND</sup> about <sup>AND</sup>ch<sub>3</sub>
Walkthrough level 38
<img file="PL190280B1_D0023.tif" />
Walkthrough level 39
190 280
<img file="PL190280B1_D0024.tif" />
<img file="PL190280B1_D0025.tif" />
Walkthrough level 41
R<sup>1</sup>
ΓΛ-CONH-CONH
Walkthrough level 42
190 280
<img file="PL190280B1_D0026.tif" />
Walkthrough level 43
Walkthrough level 44
Department of Publications of the Republic of Poland. Circulation of 50 copies Price PLN 6.00
Contents24
39 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39
67 members in 25 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 4417742 | Germany | A | |
| 4417742 | Germany | A | |
| 944417742 | – | – | – |
| DE19944417742 | – | – | – |
Members67
| Document | Office | Kind | |
|---|---|---|---|
| NO951993D0 | Norway | D0 | |
| HU9501483D0 | Hungary | D0 | |
| IL113756D0 | Israel | D0 | |
| CA2149594A1 | Canada | A1 | |
| FI952421A | Finland | A | |
| NO951993L | Norway | L | |
| EP0682869A1 | European Patent Office (EPO) | A1 | |
| DE4417742A1 | Germany | A1 | |
| PL308664A1 | Poland | A1 | |
| AU2014495A | Australia | A | |
| SK66395A3 | Slovakia | A3 | |
| KR950030803A | Republic of Korea | A | |
| ZA954107B | South Africa | B | |
| HUT71902A | Hungary | A | |
| JPH0892091A | Japan | A | |
| NZ272141A | New Zealand | A | |
| RU95107893A | Russian Federation | A | |
| CZ130995A3 | Czechia | A3 | |
| AU696581B2 | Australia | B2 | |
| TW342310B | Taiwan Province of China | B | |
| IL113756A | Israel | A | |
| UA34466C2 | Ukraine | C2 | |
| RU2166253C2 | Russian Federation | C2 | |
| US6232328B1 | United States of America | B1 | |
| US2001021716A1 | United States of America | A1 | |
| US2001027201A1 | United States of America | A1 | |
| US2001041723A1 | United States of America | A1 | |
| US2001044456A1 | United States of America | A1 | |
| HU220131B | Hungary | B | |
| US6329374B1 | United States of America | B1 | |
| JP3276808B2 | Japan | B2 | |
| AU696581C | Australia | C | |
| JP2002201131A | Japan | A | |
| US6429206B2 | United States of America | B2 | |
| CA2149594C | Canada | C | |
| CZ291031B6 | Czechia | B6 | |
| US6495573B2 | United States of America | B2 | |
| NO313901B1 | Norway | B1 | |
| KR100377187B1 | Republic of Korea | B1 | |
| FI111125B | Finland | B | |
| US6613783B2 | United States of America | B2 | |
| SK284104B6 | Slovakia | B6 | |
| US6896891B2 | United States of America | B2 | |
| US2005222217A1 | United States of America | A1 | |
| PL190280B1This record | Poland | B1 | |
| EP0682869B1 | European Patent Office (EPO) | B1 | |
| EP1609362A2 | European Patent Office (EPO) | A2 | |
| AT313261T | Austria | T | |
| ATE313261T1 | Austria | T1 | |
| DE59511031D1 | Germany | D1 | |
| DK0682869T3 | Denmark | T3 | |
| ES2255055T3 | Spain | T3 | |
| US2006276517A1 | United States of America | A1 | |
| US2008108670A1 | United States of America | A1 | |
| US2008108671A1 | United States of America | A1 | |
| US7517535B2 | United States of America | B2 | |
| EP1609362A3 | European Patent Office (EPO) | A3 | |
| JP4596714B2 | Japan | B2 | |
| US8728507B2 | United States of America | B2 | |
| EP1609362B1 | European Patent Office (EPO) | B1 | |
| DK1609362T3 | Denmark | T3 | |
| PT1609362E | Portugal | E | |
| ES2533867T3 | Spain | T3 | |
| FR15C0032I1 | France | I1 | |
| NL300733I1 | Netherlands (Kingdom of the) | I1 | |
| NL300733I2 | Netherlands (Kingdom of the) | I2 | |
| FR15C0032I2 | France | I2 |
Numbers
- Publication, DOCDB
- 190280
- Publication, EPODOC
- PL190280B
- Application
- 95308664
- Application, DOCDB
- 30866495
- Application, EPODOC
- PL19950308664
Titles2
- English
- METHOD OF NON-SYSTEMICALLY FIGHTING AGAINST PARASITES AND AGENT THEREFOR
- Polish
- Zastosowanie związków bedących agonistami i antagonistami nikotynergicznych receptorów acetylocholiny oraz kształtka do naskórnego, niesystemicznego zwalczania pasożytniczych owadów
Classification
- CPC, 9
- A01N61/00
- A01N43/40
- A01N51/00
- Y10S514/875
- A61P33/00
- Y10S514/876
- A61P33/14
- A61P43/00
- A01N43/78
- IPC, 24
- A01N43 40
- A01N51 00
- A01N61 00
- A61K31 00
- A61K31 425
- A61K31 426
- A61K31 4439
- A61K31 44
- A61K31 4427
- A61K31 444
- A61K31 495
- A61K31 53
- A61K31 54
- A61K45 00
- A61P33 00
- A61P33 14
- A61P43 00
- C07D213 61
- C07D233 64
- C07D277 10
- C07D279 06
- C07D401 04
- C07D401 06
- C07D417 06
